Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology

Comparisons of duration of response (DoR) and duration of clinical benefit (DoCB) within clinical trials are prone to biases. To address these biases, we used new methodology to prospectively analyze expected DoR and expected DoCB. Objective response rate and clinical benefit rate were calculated fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Garnett, Sally Anne, Martin, Miguel, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N., Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L., Smirnova, Iva, Lichinitser, Mikhail R., Pendergrass, Kelly, Lindemann, Justin P. O., Di Leo, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586113/
https://www.ncbi.nlm.nih.gov/pubmed/23378064
http://dx.doi.org/10.1007/s10549-012-2395-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586113/
https://www.ncbi.nlm.nih.gov/pubmed/23378064
http://dx.doi.org/10.1007/s10549-012-2395-8

Ejemplares similares